DEXCOM INC — Director's Dealing 2024

May 24, 2024

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2024-05-22

Reporting Person: ALTMAN STEVEN R (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2024-05-22	Common Stock	A	2613	$0.0	Acquired	2613	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common Stock	56017	Indirect

Footnotes

F1: The RSU Award was granted on May 22, 2024 and 100% of the RSU will vest on the earlier of the one year anniversary of the grant date or the date of DexCom, Inc.'s 2025 Annual Meeting of Stockholders. Each share is represented by a restricted stock unit (RSU) that represents a contingent right to receive one share of DexCom, Inc. Common Stock upon settlement.